Tufts Report Finds No Benefit From Routine Pulmonary Artery Catheterization
This article was originally published in The Gray Sheet
Executive Summary
Pulmonary artery catheterization for monitoring cardiac function was once common in the intensive care units, but a new technology assessment requested by the government shows there is little evidence that the procedure is effective in critical care settings
You may also be interested in...
Pulmonary Artery Catheter Use Down Sharply, Research Shows
Pulmonary artery catheterization in the United States - once common for critical care - has dropped so dramatically that it should either be discontinued entirely or performed only by physicians highly skilled in the procedure, according to articles in the July 25 Journal of the American Medical Association.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.